Tell us about your search experience on the TGA website - complete our short survey
ARTG ID 190718
ARTG Name
BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle
Product name
BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle
ARTG Date
Registration Type
Medicine
Therapeutic good type
M
Ingredients
Neisseria meningitidis Group B Factor H Binding Protein fusion protein
Neisseria meningitidis Group B Neisseria Adhesin A protein
Neisseria meningitidis Group B Neisseria Heparin Binding Antigen fusion protein
Neisseria meningitidis serogroup B outer membrane vesicles
Licence category
RE
Licence status
A
Summary
Product information
Consumer medicine information
Related information
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Laboratory test reportBEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needle (GlaxoSmithKline Australia Pty Ltd)Batch Release - PASS
- Section 14 consentGlaxoSmithKline Australia Pty Ltd, from CON-437, BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needleApproved for Import and supply while noncompliant with standards. The consent is effective from 1 July 2020 until 11 May 2021.
- Section 14 consentGlaxoSmithKline Australia Pty Ltd, from CON-862, BEXSERO - multi-component Meningococcal B vaccine (recombinant, adsorbed) suspension for injection 0.5 ml pre-filled syringe without needleApproved for Import and supply while noncompliant with standards. The consent is effective from 9 September 2021 until 23 July 2022.